Browse 1,662 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
for
Glioma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT01772771
Recruiting
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
for
Cancer
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 5+
Code: NCT00760656
Recruiting
Tumor Immunotherapy and Microbiome Analysis
for
Advanced Solid Tumor
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT04579978
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
for
Locally Advanced Cervical Cancer
Location: Montreal, Toronto, Hamilton
Sponsor: AstraZeneca
Sex: Female
Age: 15+
Code: NCT06079671
Phase 3, Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study